Filing Details
- Accession Number:
- 0001218460-10-000002
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2010-10-25 15:08:25
- Reporting Period:
- 2010-03-31
- Filing Date:
- 2010-10-25
- Accepted Time:
- 2010-10-25 15:08:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1229089 | Oncolin Therapeutics Inc. | OCOL | Pharmaceutical Preparations (2834) | 880507007 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1218460 | Kevan Casey | Po Box 87721 Houston TX 77287 | Corp Secretary | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common | Disposition | 2009-12-04 | 90,000,000 | $0.00 | 343,167,694 | No | 5 | S | Direct | |
Common | Disposition | 2010-08-19 | 60,593,640 | $0.00 | 282,574,054 | No | 4 | S | Direct | |
Common | Disposition | 2010-08-19 | 236,358,341 | $0.00 | 46,215,713 | No | 4 | S | Indirect | Voting Control |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | Voting Control |